CAH  Cardinal Health Inc.

Exchange

NYSE

Sector

Health Care

Industry

Other Pharmaceuticals

Market Cap.

16.274B

Highly Competitive Industry over the past 10 years

It's likely that CAH is in an industry with low barriers to entry, spurring high competition. If Gross Margins are at least satisfactory, it's likely CAH invests heavily in R&D and Sales, General & Administrative expenses.

Only $1.60 of every $100 of Revenue have been profit, on average over the past 10 years.
Figures in USD. Fiscal year ends in June
2002200320042005200620072008200920102011
Net Income 1.13B 1.41B 1.51B 1.05B 1.00B 1.93B 1.30B 1.15B 642.20M 959.00M
divided by
Revenue 51.14B 56.74B 65.05B 74.91B 81.36B 86.85B 91.09B 99.51B 98.50B 102.64B
Net Profit Margin 2.20% 2.48% 2.33% 1.40% 1.23% 2.22% 1.43% 1.16% 0.65% 0.93%

Weak Pricing Power over the past 10 years

CAH is likely in a highly competitive industry, due to low barriers to entry. It's because of this, that CAH has been unable to raise prices and increase their profitability. This puts them in a poor position if inflation becomes an issue, as they would struggle to pass higher costs onto consumers.

Only $6.20 of every $100 worth of sales have been Gross Profit, on average over the past 10 years.
Figures in USD. Fiscal year ends in June
2002200320042005200620072008200920102011
Gross Profit 4.05B 4.51B 4.74B 5.01B 5.28B 5.25B 5.63B 5.53B 3.78B 4.16B
divided by
Revenue 51.14B 56.74B 65.05B 74.91B 81.36B 86.85B 91.09B 99.51B 98.50B 102.64B
Gross Margin 7.91% 7.95% 7.29% 6.68% 6.49% 6.04% 6.19% 5.55% 3.84% 4.05%

Medium Capital Intensity over the past 10 years

CAH has used a reasonable amount of their financial resources to invest in facilities and equipment required to produce its goods and services. This isn't perfect, but it shouldn't be an area of concern unless this number is strongly trending upwards.

34.52% of Profits are being spent on Capital Expenditures, like Property, Plant, & Equipment, required to run the business.
Figures in USD. Fiscal year ends in June
2002200320042005200620072008200920102011
Capital Expenditure 285.40M 423.20M 410.20M 571.70M 443.20M 357.40M 376.10M 533.40M 255.80M 291.30M
divided by
Net Income 1.13B 1.41B 1.51B 1.05B 1.00B 1.93B 1.30B 1.15B 642.20M 959.00M
Capital Expenditure Ratio 25.34% 30.10% 27.11% 54.41% 44.32% 18.51% 28.92% 46.32% 39.83% 30.38%